Perrigo shares jump after CVS to cover over-the-counter birth control drug - BBG

Perrigo

04/04/2024 20:36

** Shares of Perrigo  PRGO.K  hit session high in volume
spike after Bloomberg reports CVS Health  CVS.N  will cover
PRGO's over-the-counter birth control drug Opill in the U.S
    ** PRGO last up 1.12% at $31.37; CVS most recently off 0.4%
    ** On July 13, 2023, co announced FDA approval for OTC sales
of Opill, a daily oral contraceptive
    ** On Feb 27, PRGO reported adj EPS of $0.86/sh, up 14.7%
year-on-year
    ** With today's gain, PRGO's stock is down 2.47% YTD
    ** All 4 analysts covering PRGO rate stock buy or stronger;
median PT $38.50

 (Reporting by Stephen Culp)
 ((stephen.culp@thomsonreuters.com; 646-223-6076;))